Linda Skidmore Roth RN Msn NP Mosbys 2026 Nursing Drug Reference Skidmore Nursing Drug Reference by Team IRA 2026 Mosby Libgenli Compressed (Complete And Verified Study material) (1523pages) LEARNEXAMS

Preface Increasingly, patients are relying on nurses to know every detail of health care. More important, nurses are expected to have these answers, especially when it comes to medication. Let Mosby’s 2026 Nursing Drug Reference be your answer. Our indispensable, yet compact, resource contains hundreds of monographs with several easyto-use features. NEW FEATURES This edition features: • Over 25 new drugs . . . . Included are monographs for: pacritinib (Vonjo)- for myelofibrosis deucravacitinib (Sotyktu)- for moderate to severe plaque psoriasis terlipressin (Terlivaz)- for Hepatorenal Syndrome • An ebook with easy-to-use navigation for quick access to monographs of your choice NEW FACTS This edition features more than 2000 new drug facts, including: • New drugs and dosage information • Newly researched side effects and adverse reactions • New and revised Black Box Warnings • The latest precautions, interactions, and contraindications • IV therapy updates • Revised nursing considerations • Updated patient/family teaching guidelines • Updated BEERS information • Additional combination products • Content previously included in appendixes has been moved to the monograph section for easier accessibility ORGANIZATION This reference is organized into two main sections: • Individual drug monographs (in alphabetical order by generic name) • Appendixes (identified by the wide thumb tabs on the edge) The guiding principle behind this book is to provide fast, easy access to drug information and nursing considerations. Every detail—the paper, typeface, cover, binding, use of color, and appendixes—has been carefully chosen with the user in mind. INDIVIDUAL DRUG MONOGRAPHS This book contains monographs for more than 1300 generic and 4500 trade medications. Common trade names are given for all drugs regularly used in the United States and Canada, with drugs available only in Canada identified by a maple leaf . The following information is provided, whenever possible, for safe, effective administration of each drug: High-alert status: Identifies high-alert drugs with a label and icon. Visit the Institute for Safe Medication Practices (ISMP) at http://www.ismp.org for a list of medications and drug classes with the greatest potential for patient harm if they are used in error